A 'tumour-busting' drug developed by a team led by Professor Stephen Neidle (UCL School of Pharmacy), supported by the UCL Technology Fund, which may improve the outlook for people with pancreatic cancer, is set to be trialled in patients following US regulatory approval.
Read: Evening Standard, More: UCL News
Close
